| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 543.78M | 505.44M | 499.69M | 348.00M | 330.91M |
| Gross Profit | 336.37M | 305.20M | 300.88M | 205.25M | 199.79M |
| EBITDA | 208.11M | 215.23M | 220.39M | 131.82M | 127.88M |
| Net Income | 166.60M | 171.37M | 173.73M | 107.25M | 107.66M |
Balance Sheet | |||||
| Total Assets | 1.12B | 1.01B | 930.78M | 805.56M | 784.31M |
| Cash, Cash Equivalents and Short-Term Investments | 170.48M | 227.50M | 377.38M | 264.87M | 353.38M |
| Total Debt | 20.78M | 12.11M | 12.82M | 11.32M | 13.72M |
| Total Liabilities | 149.32M | 125.17M | 122.29M | 113.68M | 111.86M |
| Stockholders Equity | 970.62M | 883.96M | 804.38M | 687.82M | 668.40M |
Cash Flow | |||||
| Free Cash Flow | 154.57M | 113.31M | 168.60M | 49.17M | 44.35M |
| Operating Cash Flow | 172.86M | 146.39M | 189.66M | 67.46M | 66.15M |
| Investing Cash Flow | -39.89M | -73.01M | -89.46M | 14.02M | -66.78M |
| Financing Cash Flow | -100.76M | -97.48M | -59.87M | -85.68M | -60.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$1.89B | 10.62 | 18.05% | 4.75% | 10.44% | -0.43% | |
73 Outperform | HK$306.25M | 6.76 | 6.01% | 7.76% | 14.80% | -56.27% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | HK$530.54M | 5.15 | 4.84% | 7.24% | -6.53% | -49.31% | |
42 Neutral | HK$314.51M | 24.82 | 6.01% | ― | -5.88% | ― | |
41 Neutral | HK$403.10M | -12.73 | 25.15% | ― | -14.87% | 25.47% | |
39 Underperform | HK$246.86M | -0.47 | -40.16% | ― | -27.42% | -80.52% |